Progreat
Payments companies reported to CMS as associated with Progreat. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Progreat, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Progreat
These are the largest totals companies reported as associated with Progreat. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kavi Devulapalli | Columbia, MO | Vascular & Interventional Radiology | $15,806.10 |
| Justin Mcwilliams | Los Angeles, CA | Vascular & Interventional Radiology | $7,150.00 |
| Faraz Khan | Reston, VA | Vascular & Interventional Radiology | $2,200.00 |
| Alex Pavidapha | Reston, VA | Vascular & Interventional Radiology | $2,200.00 |
| Ekramul Gofur | Miami, FL | Vascular & Interventional Radiology | $637.27 |
| David Johnson | Fort Myers, FL | Vascular & Interventional Radiology | $450.00 |
| Brian Wong | Louisville, KY | Vascular & Interventional Radiology | $450.00 |
| Rashed Hasan | Lynnwood, WA | Vascular & Interventional Radiology | $312.61 |
| Rolando Celis Valdiviezo | Everett, WA | Vascular Surgery | $312.61 |
| Natasha Hansraj | Houston, TX | Vascular Surgery | $236.36 |
Prescribed Progreat?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.